Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
303-03-003 ISMRM Abstract

Quantitative MRI–based Prediction of Contrast Enhancement in Brain Tumors using Deep Learning

Primary: Neuro - Tumors
Secondary: Acquisition & Reconstruction - AI methods
303-03-003 · Advanced Tumor Imaging: Bridging Research and Clinical Practice · Monday, 11 May, 4:10 PM–6:00 PM · Auditorium 1
Keywords: Deep learning T1 Mapping Contrast Enhancement Detection NnU-Net Quantitative MRI (qMRI)
Accepted
Dennis C Thomas 1,2,3,4, Sarmad A Khan4,5, Mariem Ghazouani1, Andrei Manzhurtsev1, Seyma Alcicek1,2,3,4, Ulrich Pilatus1, Elke Hattingen1,2,3,4, Florian Buettner3,4,6,7, Katharina Wenger1,2,3,4
1Goethe University, University Hospital Frankfurt, Institute of Neuroradiology and Cooperative Brain Imaging Center - CoBIC, Frankfurt am Main, Germany
2University Cancer Center Frankfurt (UCT), Frankfurt am Main, Germany
3Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany
4German Cancer Research Center (DKFZ) Heidelberg, Germany and German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Frankfurt am Main, Germany
5Institute of informatics, Goethe University, Frankfurt am Main, Germany
6Institute of Computer Science, Goethe University, Frankfurt am Main, Germany
7Goethe University, Frankfurt am Main, Germany
Presenting Author: Dennis C Thomas

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. McDonald RJ, McDonald JS, Kallmes DF, et al. Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging. Radiology. 2015;275(3):772-782. doi:10.1148/radiol.15150025 [doi]
2. Shankar PR, Parikh K, Davenport MS. Financial Implications of Revised ACR Guidelines for Estimated Glomerular Filtration Rate Testing Before Contrast-Enhanced MRI. Journal of the American College of Radiology. 2018;15(2):250-257. doi:10.1016/j.jacr.2017.10.008 [doi]
3. Rogosnitzky M, Branch S. Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms. Biometals. 2016;29:365-376. doi:10.1007/s10534-016-9931-7 [doi]
4. Gong E, Pauly JM, Wintermark M, Zaharchuk G. Deep learning enables reduced gadolinium dose for contrast-enhanced brain MRI. Journal of Magnetic Resonance Imaging. 2018;48(2):330-340. doi:10.1002/jmri.25970 [doi]
5. Kleesiek J, Morshuis JN, Isensee F, et al. Can Virtual Contrast Enhancement in Brain MRI Replace Gadolinium?: A Feasibility Study. Invest Radiol. 2019;54(10):653-660. doi:10.1097/RLI.0000000000000583 [doi]
6. Chen C, Raymond C, Speier B, et al. Synthesizing MR Image Contrast Enhancement Using 3D High-resolution ConvNets. IEEE Trans Biomed Eng. 2023;70(2):401-412. doi:10.1109/TBME.2022.3192309 [doi]
7. Moya-Sáez E, de Luis-García R, Nunez-Gonzalez L, Alberola-López C, Hernández-Tamames JA. Brain tumor enhancement prediction from pre-contrast conventional weighted images using synthetic multiparametric mapping and generative artificial intelligence. Quant Imaging Med Surg. 2025;15(1):42-54. doi:10.21037/qims-24-721 [doi]
8. Moya-Sáez E, Peña-Nogales Ó, Luis-García R de, Alberola-López C. A deep learning approach for synthetic MRI based on two routine sequences and training with synthetic data. Computer Methods and Programs in Biomedicine. 2021;210:106371. doi:10.1016/j.cmpb.2021.106371 [doi]
9. Moya-Sáez E, de Luis-García R, Alberola-López C. Toward deep learning replacement of gadolinium in neuro-oncology: A review of contrast-enhanced synthetic MRI. Front Neuroimaging. 2023;2. doi:10.3389/fnimg.2023.1055463 [doi]
10. Hattingen E, Müller A, Jurcoane A, et al. Value of quantitative magnetic resonance imaging T1-relaxometry in predicting contrast-enhancement in glioblastoma patients. Oncotarget. 2017;8(32):53542-53551. doi:10.18632/oncotarget.18612 [doi]
11. Isensee F, Jaeger PF, Kohl SAA, Petersen J, Maier-Hein KH. nnU-Net: a self-configuring method for deep learning-based biomedical image segmentation. Nat Methods. 2021;18(2):203-211. doi:10.1038/s41592-020-01008-z [doi]
12. Thomas DC, Deichmann R, Nöth U, et al. A fast protocol for multi-center, multi-parametric quantitative MRI studies in brain tumor patients using vendor sequences. Neuro-Oncology Advances. Published online July 4, 2024:vdae117. doi:10.1093/noajnl/vdae117 [doi]
13. Kofler F, Berger C, Waldmannstetter D, et al. BraTS Toolkit: Translating BraTS Brain Tumor Segmentation Algorithms Into Clinical and Scientific Practice. Front Neurosci. 2020;14. doi:10.3389/fnins.2020.00125 [doi]
14. Park MJ, Kim HS, Jahng GH, Ryu CW, Park SM, Kim SY. Semiquantitative Assessment of Intratumoral Susceptibility Signals Using Non-Contrast-Enhanced High-Field High-Resolution Susceptibility-Weighted Imaging in Patients with Gliomas: Comparison with MR Perfusion Imaging. American Journal of Neuroradiology. 2009;30(7):1402-1408. doi:10.3174/ajnr.A1593 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/303-03-003